Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Jazz Pharmaceuticals plc
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
4,039.02 |
4,232.32 |
4,424.16 |
4,710.31 |
5,036.71 |
5,296.45 |
Przychód Δ r/r |
0.00% |
4.79% |
4.53% |
6.47% |
6.93% |
5.16% |
Przychód (min) |
4,009.02 |
4,026.59 |
4,020.35 |
4,710.08 |
4,736.23 |
4,980.48 |
Przychód (max) |
4,059.01 |
4,447.86 |
4,779.26 |
4,710.55 |
5,325.32 |
5,599.95 |
EBITDA (średnia) |
1,142.59 |
1,197.28 |
1,251.55 |
1,332.50 |
1,424.83 |
1,498.31 |
EBIT (średnia) |
498.70 |
522.57 |
546.25 |
581.58 |
621.88 |
653.95 |
EBIT % |
12.35% |
12.35% |
12.35% |
12.35% |
12.35% |
12.35% |
Zysk netto (średni) |
1,332.83 |
400.80 |
1,353.76 |
778.55 |
1,736.86 |
1,845.35 |
Zysk netto % |
33.00% |
9.47% |
30.60% |
16.53% |
34.48% |
34.84% |
EPS (średnia) |
20.31 |
6.07 |
21.64 |
23.90 |
26.31 |
27.96 |
Liczba analityków (Przychody) |
16 |
13 |
17 |
15 |
6 |
11 |
Liczba analityków (EPS) |
11 |
13 |
11 |
4 |
3 |
2 |
symbol |
JAZZ |
JAZZ |
JAZZ |
JAZZ |
JAZZ |
JAZZ |